References1. Ascher H, Hahn-Zoric M, Hanson LA, Kilander AF, Nilsson LA, Tlaskalova H. Value ofserologic markers for clinical diagnosis and population studies of coeliac disease. Scand JGastroenterol. 1996;31:61–67.2. Burgin-Wolff A, Gaze H, Hadziselimovic F, et al. Antigliadin and antiendomysium antibodydetermination for coeliac disease. Arch Dis Child. 1991;66:941–947.3. Burgin-Wolff A, Berger R, Gaze H, Huber H, Lentze MJ, Nussle D. IgG, IgA and IgEgliadin antibody determinations as screening test for untreated coeliac disease in children, amulticentre study. Eur J Pediatr. 1989;148:496–502.4. Chirdo FG, Rumbo M, Carabajal P, et al. Determination of anti-omega-gliadin antibodies inserological tests for coeliac disease. Scand J Gastroenterol. 2000;35:508–516.5. Feighery C, Weir DG, Whelan A, et al. Diagnosis of gluten-sensitive enteropathy: isexclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol. 1998;10:919–925.6. Berger R, Schmidt G. Evaluation of six antigliadin antibody assays. J Immunol Methods.1996;191:77–86.7. Sacchetti L, Ferrajolo A, Salerno G, et al. Diagnostic value of various serum antibodiesdetected by diverse methods in childhood celiac disease. Clin Chem. 1996;42:1838–1842.8. Lerner A, Kumar V, Iancu TC. Immunological diagnosis of childhood coeliac disease:comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin ExpImmunol. 1994;95:78–82.9. Carroccio A, Iacono G, Montalto G, et al. Immunologic and absorptive tests in celiac disease:can they replace intestinal biopsies? Scand J Gastroenterol. 1993;28:673–676.10. Not T, Ventura A, Peticarari S, Basile S. A new, rapid, non invasive screening test for celiacdisease. J Pediatr. 1993;123:425–427.11. McMillan SA, Haughton DJ, Biggart JD, Edgar JD, Porter KG, McNeill TA. Predictive valuefor coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attendingfor jejunal biopsy. BMJ. 1991;303:1163–1165.12. Rautonen J, Rautonen N, Savilahti E. Antibodies to gliadin in children with coeliac disease.Acta Paediatr Scand. 199;80:1200–1206.13. Ribes-Koninckx C, Alfonso P, Ortigosa L, Escobar H, Suarez L, Arranz E, Mendez E. Abeta-turn rich oats peptide as an antigen in an ELISA method for screening of coeliac diseasein a paediatric population. Am J Gastroenterol. 2001 May;96(5):1536–1540.14. Corazza GR, Biagi F, Andreani ML, Gasbarrini G. Screening test for coeliac disease. Lancet.1997;349:325–326.29
15. de Lecea A, Ribes-Koninckx C, Polanco I, Calvete JF. Serological screening (antigliadin andantiendomysium antibodies) for non-overt coeliac disease in children of short stature. ActaPaediatr Suppl. 1996;412:54–55.16. Bode S, Weile B, Krasilnikoff PA, Gudmand-Hoyer E. The diagnostic value of the gliadinantibody test in celiac disease in children: A prospective study. J Pediatr Gastroenterol Nutr.1993;17:260–264.17. Mascart-Lemone F, Lambrechts A. Serology of coeliac disease: Early diagnosis andtherapeutic impact. Acta Gastroenterol Belg. 1995;58:388–396.18. Bardella MT, Molteni N, Cesana B, Baldassarri AR, Binanchi PA. IgA antigliadinantibodies, cellobiose/mannitol sugar test, and carotenemia in the diagnosis of and screeningfor celiac disease. Am J Gastroenterol. 1991;86:309–311.19. Bonamico M, Tiberti C, Picarelli A, et al. Radioimmunoassay to detect antitransglutaminaseautoantibodies is the most sensitive and specific screening method for celiac disease. Am JGastroenterol. 2001;96:1536–1540.20. Baldas V, Tommasini A, Trevisiol C, et al. <strong>Development</strong> of a novel rapid non-invasivescreening test for coeliac disease. Gut. 2000;47:628–631.21. Stern M. Comparative evaluation of serologic tests for celiac disease: a European initiativetoward standardization. J Pediatr Gastroenterol Nutr. 2000;31:513–519.22. Sulkanen S, Halttunen T, Laurila K, et al. M. Tissue transglutaminase autoantibody enzymelinkedimmunosorbent assay in detecting celiac disease. Gastroenetrology. 1998;115:1584–1586.23. Yiannakou JY, Dell’Olio D, Saaka M, et al. Detection and characterisation of antiendomysialantibody in coeliac disease using human umbilical cord. Int Arch AllergyImmunol. 1997;112:140–144.24. Carroccio A, Cavataio F, Iacono G, et al. IgA antiendomysial antibodies on the umbilicalcord in diagnosing celiac disease. Sensitivity, specificity, and comparative evaluation withthe traditional kit. Scand J Gastroenterol. 1996;31:759–763.25. Salmaso C, Ocmant A, Pesce G, et al. Comparison of ELISA for tissue transglutaminaseautoantibodies with antiendomysium antibodies in pediatric and adult patients with celiacdisease. Allergy. 2001;56:544–547.26. Sblattero D, Berti I, Trevisiol C, et al. Human recombinant tissue transglutaminase ELISA:an innovative diagnostic assay for celiac disease. Am J Gastroenterol. 2000;95:1253–1257.27. Sategna-Guidetti C, Grosso SB, Bruno M, Grosso S. Is human umbilical cord the mostsuitable substrate for the detection of endomysium antibodies in the screening and follow-upof coeliac disease? Eur J Gastroenterol Hepatol. 1997;9:655–656.30
- Page 1 and 2: NIH Consensus Development Conferenc
- Page 3 and 4: III. What Are the Manifestations an
- Page 5 and 6: • What is the management of celia
- Page 7 and 8: Monday, June 28, 2004 (continued)I.
- Page 9 and 10: Monday, June 28, 2004 (continued)II
- Page 11 and 12: Wednesday, June 30, 2004 (continued
- Page 13 and 14: Lisa H. RichardsonConsumer Represen
- Page 15 and 16: Ciaran P. Kelly, M.D.Director, Celi
- Page 17 and 18: Van S. Hubbard, M.D., Ph.D.Director
- Page 19 and 20: AbstractsThe following are abstract
- Page 21 and 22: susceptibility (e.g., DR17 homozygo
- Page 23 and 24: The Pathology of Celiac DiseaseDavi
- Page 25 and 26: In this regard, the transport pathw
- Page 27: for the IgG-based test, while speci
- Page 31 and 32: Clinical Algorithm in Celiac Diseas
- Page 33 and 34: Considera diagnosisof celiac diseas
- Page 35 and 36: There are populations at particular
- Page 37 and 38: Serological Testing for Celiac Dise
- Page 39 and 40: Estimates of the sensitivity of the
- Page 41 and 42: the risk and severity of CD may als
- Page 43 and 44: What Are the Prevalence and Inciden
- Page 45 and 46: ascribed to excess menstrual loss.
- Page 47 and 48: ReferencesFamily History of Celiac
- Page 49 and 50: Carroccio A, Iannitto E, Cavataio F
- Page 51 and 52: identified by surveys or through so
- Page 53 and 54: Clinical Presentation of Celiac Dis
- Page 55 and 56: een widely reported. The question r
- Page 57 and 58: The Many Faces of Celiac Disease: C
- Page 59 and 60: References1. Green PH, Jabri B. Coe
- Page 61 and 62: Association of Celiac Disease and G
- Page 63 and 64: Does the Gluten-Free Diet Protect F
- Page 65 and 66: Skin Manifestations of Celiac Disea
- Page 67 and 68: allow a better understanding of the
- Page 69 and 70: 4. Henriksson KG, Hallert C, Walan
- Page 71 and 72: characterized, clinically-identifie
- Page 73 and 74: 10. Hoffenberg EJ, Emery LM, Barrig
- Page 75 and 76: ataxia, epilepsy with posterior cer
- Page 77 and 78: Consequences of Testing for Celiac
- Page 79 and 80:
Osteoporosis/FracturesThere were 11
- Page 81 and 82:
Dietary Guidelines for Celiac Disea
- Page 85 and 86:
21. Thompson T. Thiamin, riboflavin
- Page 88 and 89:
In order to effectively counsel ind
- Page 90 and 91:
9. Hallert C, Granno C, Hulten S, M
- Page 92 and 93:
adhered to the GFD after more than
- Page 94 and 95:
Patient education, close supervisio
- Page 96:
26. Mustalahti K, Lohiniemi S, Laip